Kehittyneet glykaation lopputuotteet (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kehittyneet glykaation lopputuotteet" in Finnish language version.

refsWebsite

Global rank Finnish rank

36nih.gov

4^th place

12^th place

27worldcat.org

5^th place

9^th place

23doi.org

2^nd place

10^th place

2sciencedirect.com

149^th place

237^th place

2oup.com

485^th place

642^nd place

2wiley.com

222^nd place

202^nd place

1tandfonline.com

507^th place

559^th place

1physiology.org

5,293^rd place

3,135^th place

1kidney-international.org

low place

1diabetesjournals.org

low place

8,580^th place

1journal-of-hepatology.eu

low place

1diabetesresearchclinicalpractice.com

low place

1nature.com

234^th place

201^st place

1rsc.org

2,020^th place

2,513^th place

1toukastress.jp

low place

1ovid.com

low place

1web.archive.org

1^st place

1liebertpub.com

low place

diabetesjournals.org

diabetes.diabetesjournals.org

AS Charonis, EC Tsilbary: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes, lokakuu 1992, 41. vsk, nro Suppl 2, s. 49–51. PubMed:1526336 doi:10.2337/diab.41.2.S49 ISSN 0012-1797 Artikkelin verkkoversio.

diabetesresearchclinicalpractice.com

P Urios, AM Grigorova-Borsos, M Sternberg: Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen. Diabetes Research and Clinical Practice, 2007, 77. vsk, nro 2, s. 337–340. doi:10.1016/j.diabres.2006.12.024 Artikkelin verkkoversio.

doi.org

dx.doi.org

G Vistoli, D De Maddis, A Cipak, N Zarkovic, M Carini, G Aldini: Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radical Research, elokuu 2013, 47. vsk, nro 47 Suppl 1, s. 3–27. PubMed:23767955 doi:10.3109/10715762.2013.815348 ISSN 1029-2470 Artikkelin verkkoversio.
P Gkogkolou, M Böhm: Advanced glycation end products. Dermato-endocrinology, 1.7.2012, 4. vsk, nro 3, s. 259–270. PubMed:23467327 doi:10.4161/derm.22028 ISSN 1938-1972 Artikkelin verkkoversio.
JM Haus, JA Carrithers, SW Trappe, TA Trappe: Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. Journal of Applied Physiology (Bethesda, Md.: 1985), joulukuu 2007, 103. vsk, nro 6, s. 2068–2076. PubMed:17901242 doi:10.1152/japplphysiol.00670.2007 ISSN 8750-7587 Artikkelin verkkoversio.
CC Zouboulis, E Makrantonaki: Clinical aspects and molecular diagnostics of skin aging. Clinics in Dermatology, tammikuu 2011, 29. vsk, nro 1, s. 3–14. PubMed:21146726 doi:10.1016/j.clindermatol.2010.07.001 ISSN 1879-1131 Artikkelin verkkoversio.
J Uribarri, S Woodruff, S Goodman, W Cai, X Chen, R Pyzik: Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet. Journal of the American Dietetic Association, kesäkuu 2010, 110. vsk, nro 6, s. 911–16.e12. PubMed:20497781 doi:10.1016/j.jada.2010.03.018 ISSN 0002-8223 Artikkelin verkkoversio.
G Basta, AM Schmidt, R De Caterina: Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovascular Research, 1.9.2004, 63. vsk, nro 4, s. 582–592. PubMed:15306213 doi:10.1016/j.cardiores.2004.05.001 ISSN 0008-6363 Artikkelin verkkoversio.
X Jin, T Yao, Z Zhou, J Zhu, S Zhang, W Hu: Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway. BioMed Research International, 2015, 2015. vsk. PubMed:26114112 doi:10.1155/2015/732450 ISSN 2314-6133 Artikkelin verkkoversio.
A Hirose, T Tanikawa, H Mori, Y Okada, Y Tanaka: Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS letters, 4.1.2010, 584. vsk, nro 1, s. 61–66. PubMed:19944695 doi:10.1016/j.febslet.2009.11.082 ISSN 1873-3468 Artikkelin verkkoversio.^{[vanhentunut linkki]}
X Ren, L Ren, Q Wei, H Shao, L Chen, N Liu: Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Cardiovascular Diabetology, 20.4.2017, 16. vsk, nro 1. PubMed:28427390 doi:10.1186/s12933-017-0531-9 ISSN 1475-2840 Artikkelin verkkoversio.
C Delgado-Andrade: New Knowledge in Analytical, Technological, and Biological Aspects of the Maillard Reaction. Foods, 26.5.2017, 6. vsk, nro 6. PubMed:28587130 doi:10.3390/foods6060040 ISSN 2304-8158 Artikkelin verkkoversio.
SB Schwedler, T Metzger, R Schinzel, C Wanner: Advanced glycation end products and mortality in hemodialysis patients. Kidney International, heinäkuu 2002, 62. vsk, nro 1, s. 301–310. PubMed:12081592 doi:10.1046/j.1523-1755.2002.00423.x ISSN 0085-2538 Artikkelin verkkoversio.
AS Charonis, EC Tsilbary: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes, lokakuu 1992, 41. vsk, nro Suppl 2, s. 49–51. PubMed:1526336 doi:10.2337/diab.41.2.S49 ISSN 0012-1797 Artikkelin verkkoversio.
B Duran-Jimenez, D Dobler, S Moffatt, N Rabbani, CH Streuli, PJ Thornalley: Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in Diabetes. Diabetes, joulukuu 2009, 58. vsk, nro 12, s. 2893–2903. PubMed:19720799 doi:10.2337/db09-0320 ISSN 0012-1797 Artikkelin verkkoversio.
D Svistounov, B Smedsrød: Hepatic clearance of advanced glycation end products (AGEs)-myth or truth? Journal of Hepatology, joulukuu 2004, 41. vsk, nro 6, s. 1038–1040. PubMed:15582139 doi:10.1016/j.jhep.2004.10.004 ISSN 0168-8278 Artikkelin verkkoversio.
P Urios, AM Grigorova-Borsos, M Sternberg: Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen. Diabetes Research and Clinical Practice, 2007, 77. vsk, nro 2, s. 337–340. doi:10.1016/j.diabres.2006.12.024 Artikkelin verkkoversio.
R Nagai, DB Murray, TO Metz, JW Baynes: Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications. Diabetes, maaliskuu 2012, 61. vsk, nro 3, s. 549–559. PubMed:22354928 doi:10.2337/db11-1120 ISSN 0012-1797 Artikkelin verkkoversio.
Z Zhou, Y Tang, X Jin, C Chen, Y Lu, L Liu: Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression. Journal of Diabetes Research, 2016, 2016. vsk. PubMed:27761470 doi:10.1155/2016/4847812 ISSN 2314-6745 Artikkelin verkkoversio.
GL Bakris, AJ Bank, DA Kass, JM Neutel, RA Preston, S Oparil: Advanced glycation end-product cross-link breakers, A novel approach to cardiovascular pathologies related to the aging process. American Journal of Hypertension, 1.12.2004, 17. vsk, nro S3, s. 23S–30S. doi:10.1016/j.amjhyper.2004.08.022 ISSN 0895-7061 Artikkelin verkkoversio.
S Vasan, X Zhang, X Zhang, A Kapurniotu, J Bernhagen, S Teichberg: An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature, 18.7.1996, 382. vsk, nro 6588, s. 275–278. PubMed:8717046 doi:10.1038/382275a0 ISSN 0028-0836 Artikkelin verkkoversio.
X Zhang, S Hu, F Chen, M Wang: Treatment of proteins with dietary polyphenols lowers the formation of AGEs and AGE-induced toxicity. Food & Function, lokakuu 2014, 5. vsk, nro 10, s. 2656–2661. PubMed:25208810 doi:10.1039/c4fo00244j ISSN 2042-650X Artikkelin verkkoversio.
SJ Zieman, V Melenovsky, L Clattenburg, MC Corretti, A Capriotti, G Gerstenblith: Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. Journal of Hypertension, maaliskuu 2007, 25. vsk, nro 3, s. 577–583. PubMed:17278974 doi:10.1097/HJH.0b013e328013e7dd ISSN 0263-6352 Artikkelin verkkoversio.
VM Monnier, GT Mustata, KL Biemel, O Reihl, MO Lederer, D Zhenyu: Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution". Annals of the New York Academy of Sciences, kesäkuu 2005, 1043. vsk, nro 1, s. 533–544. PubMed:16037276 doi:10.1196/annals.1333.061 ISSN 0077-8923 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
JD Furber: Extracellular glycation crosslinks: prospects for removal. Rejuvenation Research, 2006, 9. vsk, nro 2, s. 274–278. PubMed:16706655 doi:10.1089/rej.2006.9.274 ISSN 1549-1684 Artikkelin verkkoversio.

journal-of-hepatology.eu

D Svistounov, B Smedsrød: Hepatic clearance of advanced glycation end products (AGEs)-myth or truth? Journal of Hepatology, joulukuu 2004, 41. vsk, nro 6, s. 1038–1040. PubMed:15582139 doi:10.1016/j.jhep.2004.10.004 ISSN 0168-8278 Artikkelin verkkoversio.

kidney-international.org

SB Schwedler, T Metzger, R Schinzel, C Wanner: Advanced glycation end products and mortality in hemodialysis patients. Kidney International, heinäkuu 2002, 62. vsk, nro 1, s. 301–310. PubMed:12081592 doi:10.1046/j.1523-1755.2002.00423.x ISSN 0085-2538 Artikkelin verkkoversio.

liebertpub.com

JD Furber: Extracellular glycation crosslinks: prospects for removal. Rejuvenation Research, 2006, 9. vsk, nro 2, s. 274–278. PubMed:16706655 doi:10.1089/rej.2006.9.274 ISSN 1549-1684 Artikkelin verkkoversio.

nature.com

S Vasan, X Zhang, X Zhang, A Kapurniotu, J Bernhagen, S Teichberg: An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature, 18.7.1996, 382. vsk, nro 6588, s. 275–278. PubMed:8717046 doi:10.1038/382275a0 ISSN 0028-0836 Artikkelin verkkoversio.

nih.gov

pubmed.ncbi.nlm.nih.gov

G Vistoli, D De Maddis, A Cipak, N Zarkovic, M Carini, G Aldini: Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radical Research, elokuu 2013, 47. vsk, nro 47 Suppl 1, s. 3–27. PubMed:23767955 doi:10.3109/10715762.2013.815348 ISSN 1029-2470 Artikkelin verkkoversio.
P Gkogkolou, M Böhm: Advanced glycation end products. Dermato-endocrinology, 1.7.2012, 4. vsk, nro 3, s. 259–270. PubMed:23467327 doi:10.4161/derm.22028 ISSN 1938-1972 Artikkelin verkkoversio.
A Stevens: The contribution of glycation to cataract formation in diabetes. Journal of the American Optometric Association, elokuu 1998, 69. vsk, nro 8, s. 519–530. PubMed:9747048 ISSN 0003-0244
JM Haus, JA Carrithers, SW Trappe, TA Trappe: Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. Journal of Applied Physiology (Bethesda, Md.: 1985), joulukuu 2007, 103. vsk, nro 6, s. 2068–2076. PubMed:17901242 doi:10.1152/japplphysiol.00670.2007 ISSN 8750-7587 Artikkelin verkkoversio.
CC Zouboulis, E Makrantonaki: Clinical aspects and molecular diagnostics of skin aging. Clinics in Dermatology, tammikuu 2011, 29. vsk, nro 1, s. 3–14. PubMed:21146726 doi:10.1016/j.clindermatol.2010.07.001 ISSN 1879-1131 Artikkelin verkkoversio.
J Uribarri, S Woodruff, S Goodman, W Cai, X Chen, R Pyzik: Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet. Journal of the American Dietetic Association, kesäkuu 2010, 110. vsk, nro 6, s. 911–16.e12. PubMed:20497781 doi:10.1016/j.jada.2010.03.018 ISSN 0002-8223 Artikkelin verkkoversio.
G Basta, AM Schmidt, R De Caterina: Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovascular Research, 1.9.2004, 63. vsk, nro 4, s. 582–592. PubMed:15306213 doi:10.1016/j.cardiores.2004.05.001 ISSN 0008-6363 Artikkelin verkkoversio.
M Oleniuc, I Secara, M Onofriescu, S Hogas, L Voroneanu, D Siriopol: Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique – Skin Autofluorescence. Mædica, lokakuu 2011, 6. vsk, nro 4, s. 298–307. PubMed:22879845 ISSN 1841-9038 Artikkelin verkkoversio.
X Jin, T Yao, Z Zhou, J Zhu, S Zhang, W Hu: Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway. BioMed Research International, 2015, 2015. vsk. PubMed:26114112 doi:10.1155/2015/732450 ISSN 2314-6133 Artikkelin verkkoversio.
A Hirose, T Tanikawa, H Mori, Y Okada, Y Tanaka: Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS letters, 4.1.2010, 584. vsk, nro 1, s. 61–66. PubMed:19944695 doi:10.1016/j.febslet.2009.11.082 ISSN 1873-3468 Artikkelin verkkoversio.^{[vanhentunut linkki]}
X Ren, L Ren, Q Wei, H Shao, L Chen, N Liu: Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Cardiovascular Diabetology, 20.4.2017, 16. vsk, nro 1. PubMed:28427390 doi:10.1186/s12933-017-0531-9 ISSN 1475-2840 Artikkelin verkkoversio.
C Delgado-Andrade: New Knowledge in Analytical, Technological, and Biological Aspects of the Maillard Reaction. Foods, 26.5.2017, 6. vsk, nro 6. PubMed:28587130 doi:10.3390/foods6060040 ISSN 2304-8158 Artikkelin verkkoversio.
SB Schwedler, T Metzger, R Schinzel, C Wanner: Advanced glycation end products and mortality in hemodialysis patients. Kidney International, heinäkuu 2002, 62. vsk, nro 1, s. 301–310. PubMed:12081592 doi:10.1046/j.1523-1755.2002.00423.x ISSN 0085-2538 Artikkelin verkkoversio.
A Gugliucci, M Bendayan: Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia, helmikuu 1996, 39. vsk, nro 2, s. 149–160. PubMed:8635666 ISSN 0012-186X
AS Charonis, EC Tsilbary: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes, lokakuu 1992, 41. vsk, nro Suppl 2, s. 49–51. PubMed:1526336 doi:10.2337/diab.41.2.S49 ISSN 0012-1797 Artikkelin verkkoversio.
B Duran-Jimenez, D Dobler, S Moffatt, N Rabbani, CH Streuli, PJ Thornalley: Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in Diabetes. Diabetes, joulukuu 2009, 58. vsk, nro 12, s. 2893–2903. PubMed:19720799 doi:10.2337/db09-0320 ISSN 0012-1797 Artikkelin verkkoversio.
B Smedsrød, J Melkko, N Araki, H Sano, S Horiuchi: Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochemical Journal, 1.3.1997, 322. vsk, nro Pt 2, s. 567–573. PubMed:9065778 ISSN 0264-6021 Artikkelin verkkoversio.
D Svistounov, B Smedsrød: Hepatic clearance of advanced glycation end products (AGEs)-myth or truth? Journal of Hepatology, joulukuu 2004, 41. vsk, nro 6, s. 1038–1040. PubMed:15582139 doi:10.1016/j.jhep.2004.10.004 ISSN 0168-8278 Artikkelin verkkoversio.
S Rahbar, JL Figarola: Novel inhibitors of advanced glycation endproducts. Archives of Biochemistry and Biophysics, 1.11.2003, 419. vsk, nro 1, s. 63–79. PubMed:14568010 ISSN 0003-9861 Artikkelin verkkoversio.
R Nagai, DB Murray, TO Metz, JW Baynes: Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications. Diabetes, maaliskuu 2012, 61. vsk, nro 3, s. 549–559. PubMed:22354928 doi:10.2337/db11-1120 ISSN 0012-1797 Artikkelin verkkoversio.
Z Zhou, Y Tang, X Jin, C Chen, Y Lu, L Liu: Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression. Journal of Diabetes Research, 2016, 2016. vsk. PubMed:27761470 doi:10.1155/2016/4847812 ISSN 2314-6745 Artikkelin verkkoversio.
S Vasan, X Zhang, X Zhang, A Kapurniotu, J Bernhagen, S Teichberg: An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature, 18.7.1996, 382. vsk, nro 6588, s. 275–278. PubMed:8717046 doi:10.1038/382275a0 ISSN 0028-0836 Artikkelin verkkoversio.
X Zhang, S Hu, F Chen, M Wang: Treatment of proteins with dietary polyphenols lowers the formation of AGEs and AGE-induced toxicity. Food & Function, lokakuu 2014, 5. vsk, nro 10, s. 2656–2661. PubMed:25208810 doi:10.1039/c4fo00244j ISSN 2042-650X Artikkelin verkkoversio.
SJ Zieman, V Melenovsky, L Clattenburg, MC Corretti, A Capriotti, G Gerstenblith: Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. Journal of Hypertension, maaliskuu 2007, 25. vsk, nro 3, s. 577–583. PubMed:17278974 doi:10.1097/HJH.0b013e328013e7dd ISSN 0263-6352 Artikkelin verkkoversio.
VM Monnier, GT Mustata, KL Biemel, O Reihl, MO Lederer, D Zhenyu: Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution". Annals of the New York Academy of Sciences, kesäkuu 2005, 1043. vsk, nro 1, s. 533–544. PubMed:16037276 doi:10.1196/annals.1333.061 ISSN 0077-8923 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
JD Furber: Extracellular glycation crosslinks: prospects for removal. Rejuvenation Research, 2006, 9. vsk, nro 2, s. 274–278. PubMed:16706655 doi:10.1089/rej.2006.9.274 ISSN 1549-1684 Artikkelin verkkoversio.

ncbi.nlm.nih.gov

P Gkogkolou, M Böhm: Advanced glycation end products. Dermato-endocrinology, 1.7.2012, 4. vsk, nro 3, s. 259–270. PubMed:23467327 doi:10.4161/derm.22028 ISSN 1938-1972 Artikkelin verkkoversio.
J Uribarri, S Woodruff, S Goodman, W Cai, X Chen, R Pyzik: Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet. Journal of the American Dietetic Association, kesäkuu 2010, 110. vsk, nro 6, s. 911–16.e12. PubMed:20497781 doi:10.1016/j.jada.2010.03.018 ISSN 0002-8223 Artikkelin verkkoversio.
M Oleniuc, I Secara, M Onofriescu, S Hogas, L Voroneanu, D Siriopol: Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique – Skin Autofluorescence. Mædica, lokakuu 2011, 6. vsk, nro 4, s. 298–307. PubMed:22879845 ISSN 1841-9038 Artikkelin verkkoversio.
X Jin, T Yao, Z Zhou, J Zhu, S Zhang, W Hu: Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway. BioMed Research International, 2015, 2015. vsk. PubMed:26114112 doi:10.1155/2015/732450 ISSN 2314-6133 Artikkelin verkkoversio.
X Ren, L Ren, Q Wei, H Shao, L Chen, N Liu: Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Cardiovascular Diabetology, 20.4.2017, 16. vsk, nro 1. PubMed:28427390 doi:10.1186/s12933-017-0531-9 ISSN 1475-2840 Artikkelin verkkoversio.
C Delgado-Andrade: New Knowledge in Analytical, Technological, and Biological Aspects of the Maillard Reaction. Foods, 26.5.2017, 6. vsk, nro 6. PubMed:28587130 doi:10.3390/foods6060040 ISSN 2304-8158 Artikkelin verkkoversio.
B Duran-Jimenez, D Dobler, S Moffatt, N Rabbani, CH Streuli, PJ Thornalley: Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in Diabetes. Diabetes, joulukuu 2009, 58. vsk, nro 12, s. 2893–2903. PubMed:19720799 doi:10.2337/db09-0320 ISSN 0012-1797 Artikkelin verkkoversio.
B Smedsrød, J Melkko, N Araki, H Sano, S Horiuchi: Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochemical Journal, 1.3.1997, 322. vsk, nro Pt 2, s. 567–573. PubMed:9065778 ISSN 0264-6021 Artikkelin verkkoversio.
R Nagai, DB Murray, TO Metz, JW Baynes: Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications. Diabetes, maaliskuu 2012, 61. vsk, nro 3, s. 549–559. PubMed:22354928 doi:10.2337/db11-1120 ISSN 0012-1797 Artikkelin verkkoversio.
Z Zhou, Y Tang, X Jin, C Chen, Y Lu, L Liu: Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression. Journal of Diabetes Research, 2016, 2016. vsk. PubMed:27761470 doi:10.1155/2016/4847812 ISSN 2314-6745 Artikkelin verkkoversio.

oup.com

academic.oup.com

G Basta, AM Schmidt, R De Caterina: Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovascular Research, 1.9.2004, 63. vsk, nro 4, s. 582–592. PubMed:15306213 doi:10.1016/j.cardiores.2004.05.001 ISSN 0008-6363 Artikkelin verkkoversio.
GL Bakris, AJ Bank, DA Kass, JM Neutel, RA Preston, S Oparil: Advanced glycation end-product cross-link breakers, A novel approach to cardiovascular pathologies related to the aging process. American Journal of Hypertension, 1.12.2004, 17. vsk, nro S3, s. 23S–30S. doi:10.1016/j.amjhyper.2004.08.022 ISSN 0895-7061 Artikkelin verkkoversio.

ovid.com

insights.ovid.com

SJ Zieman, V Melenovsky, L Clattenburg, MC Corretti, A Capriotti, G Gerstenblith: Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. Journal of Hypertension, maaliskuu 2007, 25. vsk, nro 3, s. 577–583. PubMed:17278974 doi:10.1097/HJH.0b013e328013e7dd ISSN 0263-6352 Artikkelin verkkoversio.

physiology.org

JM Haus, JA Carrithers, SW Trappe, TA Trappe: Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. Journal of Applied Physiology (Bethesda, Md.: 1985), joulukuu 2007, 103. vsk, nro 6, s. 2068–2076. PubMed:17901242 doi:10.1152/japplphysiol.00670.2007 ISSN 8750-7587 Artikkelin verkkoversio.

rsc.org

pubs.rsc.org

X Zhang, S Hu, F Chen, M Wang: Treatment of proteins with dietary polyphenols lowers the formation of AGEs and AGE-induced toxicity. Food & Function, lokakuu 2014, 5. vsk, nro 10, s. 2656–2661. PubMed:25208810 doi:10.1039/c4fo00244j ISSN 2042-650X Artikkelin verkkoversio.

sciencedirect.com

CC Zouboulis, E Makrantonaki: Clinical aspects and molecular diagnostics of skin aging. Clinics in Dermatology, tammikuu 2011, 29. vsk, nro 1, s. 3–14. PubMed:21146726 doi:10.1016/j.clindermatol.2010.07.001 ISSN 1879-1131 Artikkelin verkkoversio.
S Rahbar, JL Figarola: Novel inhibitors of advanced glycation endproducts. Archives of Biochemistry and Biophysics, 1.11.2003, 419. vsk, nro 1, s. 63–79. PubMed:14568010 ISSN 0003-9861 Artikkelin verkkoversio.

tandfonline.com

G Vistoli, D De Maddis, A Cipak, N Zarkovic, M Carini, G Aldini: Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radical Research, elokuu 2013, 47. vsk, nro 47 Suppl 1, s. 3–27. PubMed:23767955 doi:10.3109/10715762.2013.815348 ISSN 1029-2470 Artikkelin verkkoversio.

toukastress.jp

D Jean, M Pouligon, C Dalle: Evaluation in vitro of AGE-crosslinks breaking ability of rosmarinic acid (pdf) 31.12.2015. Glycative Stress Research. Viitattu 16.10.2017.

web.archive.org

VM Monnier, GT Mustata, KL Biemel, O Reihl, MO Lederer, D Zhenyu: Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution". Annals of the New York Academy of Sciences, kesäkuu 2005, 1043. vsk, nro 1, s. 533–544. PubMed:16037276 doi:10.1196/annals.1333.061 ISSN 0077-8923 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)

wiley.com

febs.onlinelibrary.wiley.com

A Hirose, T Tanikawa, H Mori, Y Okada, Y Tanaka: Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS letters, 4.1.2010, 584. vsk, nro 1, s. 61–66. PubMed:19944695 doi:10.1016/j.febslet.2009.11.082 ISSN 1873-3468 Artikkelin verkkoversio.^{[vanhentunut linkki]}

nyaspubs.onlinelibrary.wiley.com

VM Monnier, GT Mustata, KL Biemel, O Reihl, MO Lederer, D Zhenyu: Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution". Annals of the New York Academy of Sciences, kesäkuu 2005, 1043. vsk, nro 1, s. 533–544. PubMed:16037276 doi:10.1196/annals.1333.061 ISSN 0077-8923 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)

worldcat.org

G Vistoli, D De Maddis, A Cipak, N Zarkovic, M Carini, G Aldini: Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radical Research, elokuu 2013, 47. vsk, nro 47 Suppl 1, s. 3–27. PubMed:23767955 doi:10.3109/10715762.2013.815348 ISSN 1029-2470 Artikkelin verkkoversio.
P Gkogkolou, M Böhm: Advanced glycation end products. Dermato-endocrinology, 1.7.2012, 4. vsk, nro 3, s. 259–270. PubMed:23467327 doi:10.4161/derm.22028 ISSN 1938-1972 Artikkelin verkkoversio.
A Stevens: The contribution of glycation to cataract formation in diabetes. Journal of the American Optometric Association, elokuu 1998, 69. vsk, nro 8, s. 519–530. PubMed:9747048 ISSN 0003-0244
JM Haus, JA Carrithers, SW Trappe, TA Trappe: Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. Journal of Applied Physiology (Bethesda, Md.: 1985), joulukuu 2007, 103. vsk, nro 6, s. 2068–2076. PubMed:17901242 doi:10.1152/japplphysiol.00670.2007 ISSN 8750-7587 Artikkelin verkkoversio.
CC Zouboulis, E Makrantonaki: Clinical aspects and molecular diagnostics of skin aging. Clinics in Dermatology, tammikuu 2011, 29. vsk, nro 1, s. 3–14. PubMed:21146726 doi:10.1016/j.clindermatol.2010.07.001 ISSN 1879-1131 Artikkelin verkkoversio.
J Uribarri, S Woodruff, S Goodman, W Cai, X Chen, R Pyzik: Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet. Journal of the American Dietetic Association, kesäkuu 2010, 110. vsk, nro 6, s. 911–16.e12. PubMed:20497781 doi:10.1016/j.jada.2010.03.018 ISSN 0002-8223 Artikkelin verkkoversio.
G Basta, AM Schmidt, R De Caterina: Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovascular Research, 1.9.2004, 63. vsk, nro 4, s. 582–592. PubMed:15306213 doi:10.1016/j.cardiores.2004.05.001 ISSN 0008-6363 Artikkelin verkkoversio.
M Oleniuc, I Secara, M Onofriescu, S Hogas, L Voroneanu, D Siriopol: Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique – Skin Autofluorescence. Mædica, lokakuu 2011, 6. vsk, nro 4, s. 298–307. PubMed:22879845 ISSN 1841-9038 Artikkelin verkkoversio.
X Jin, T Yao, Z Zhou, J Zhu, S Zhang, W Hu: Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway. BioMed Research International, 2015, 2015. vsk. PubMed:26114112 doi:10.1155/2015/732450 ISSN 2314-6133 Artikkelin verkkoversio.
A Hirose, T Tanikawa, H Mori, Y Okada, Y Tanaka: Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS letters, 4.1.2010, 584. vsk, nro 1, s. 61–66. PubMed:19944695 doi:10.1016/j.febslet.2009.11.082 ISSN 1873-3468 Artikkelin verkkoversio.^{[vanhentunut linkki]}
X Ren, L Ren, Q Wei, H Shao, L Chen, N Liu: Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Cardiovascular Diabetology, 20.4.2017, 16. vsk, nro 1. PubMed:28427390 doi:10.1186/s12933-017-0531-9 ISSN 1475-2840 Artikkelin verkkoversio.
C Delgado-Andrade: New Knowledge in Analytical, Technological, and Biological Aspects of the Maillard Reaction. Foods, 26.5.2017, 6. vsk, nro 6. PubMed:28587130 doi:10.3390/foods6060040 ISSN 2304-8158 Artikkelin verkkoversio.
SB Schwedler, T Metzger, R Schinzel, C Wanner: Advanced glycation end products and mortality in hemodialysis patients. Kidney International, heinäkuu 2002, 62. vsk, nro 1, s. 301–310. PubMed:12081592 doi:10.1046/j.1523-1755.2002.00423.x ISSN 0085-2538 Artikkelin verkkoversio.
A Gugliucci, M Bendayan: Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia, helmikuu 1996, 39. vsk, nro 2, s. 149–160. PubMed:8635666 ISSN 0012-186X
AS Charonis, EC Tsilbary: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes, lokakuu 1992, 41. vsk, nro Suppl 2, s. 49–51. PubMed:1526336 doi:10.2337/diab.41.2.S49 ISSN 0012-1797 Artikkelin verkkoversio.
B Duran-Jimenez, D Dobler, S Moffatt, N Rabbani, CH Streuli, PJ Thornalley: Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in Diabetes. Diabetes, joulukuu 2009, 58. vsk, nro 12, s. 2893–2903. PubMed:19720799 doi:10.2337/db09-0320 ISSN 0012-1797 Artikkelin verkkoversio.
B Smedsrød, J Melkko, N Araki, H Sano, S Horiuchi: Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochemical Journal, 1.3.1997, 322. vsk, nro Pt 2, s. 567–573. PubMed:9065778 ISSN 0264-6021 Artikkelin verkkoversio.
D Svistounov, B Smedsrød: Hepatic clearance of advanced glycation end products (AGEs)-myth or truth? Journal of Hepatology, joulukuu 2004, 41. vsk, nro 6, s. 1038–1040. PubMed:15582139 doi:10.1016/j.jhep.2004.10.004 ISSN 0168-8278 Artikkelin verkkoversio.
S Rahbar, JL Figarola: Novel inhibitors of advanced glycation endproducts. Archives of Biochemistry and Biophysics, 1.11.2003, 419. vsk, nro 1, s. 63–79. PubMed:14568010 ISSN 0003-9861 Artikkelin verkkoversio.
R Nagai, DB Murray, TO Metz, JW Baynes: Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications. Diabetes, maaliskuu 2012, 61. vsk, nro 3, s. 549–559. PubMed:22354928 doi:10.2337/db11-1120 ISSN 0012-1797 Artikkelin verkkoversio.
Z Zhou, Y Tang, X Jin, C Chen, Y Lu, L Liu: Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression. Journal of Diabetes Research, 2016, 2016. vsk. PubMed:27761470 doi:10.1155/2016/4847812 ISSN 2314-6745 Artikkelin verkkoversio.
GL Bakris, AJ Bank, DA Kass, JM Neutel, RA Preston, S Oparil: Advanced glycation end-product cross-link breakers, A novel approach to cardiovascular pathologies related to the aging process. American Journal of Hypertension, 1.12.2004, 17. vsk, nro S3, s. 23S–30S. doi:10.1016/j.amjhyper.2004.08.022 ISSN 0895-7061 Artikkelin verkkoversio.
S Vasan, X Zhang, X Zhang, A Kapurniotu, J Bernhagen, S Teichberg: An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature, 18.7.1996, 382. vsk, nro 6588, s. 275–278. PubMed:8717046 doi:10.1038/382275a0 ISSN 0028-0836 Artikkelin verkkoversio.
X Zhang, S Hu, F Chen, M Wang: Treatment of proteins with dietary polyphenols lowers the formation of AGEs and AGE-induced toxicity. Food & Function, lokakuu 2014, 5. vsk, nro 10, s. 2656–2661. PubMed:25208810 doi:10.1039/c4fo00244j ISSN 2042-650X Artikkelin verkkoversio.
SJ Zieman, V Melenovsky, L Clattenburg, MC Corretti, A Capriotti, G Gerstenblith: Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. Journal of Hypertension, maaliskuu 2007, 25. vsk, nro 3, s. 577–583. PubMed:17278974 doi:10.1097/HJH.0b013e328013e7dd ISSN 0263-6352 Artikkelin verkkoversio.
VM Monnier, GT Mustata, KL Biemel, O Reihl, MO Lederer, D Zhenyu: Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution". Annals of the New York Academy of Sciences, kesäkuu 2005, 1043. vsk, nro 1, s. 533–544. PubMed:16037276 doi:10.1196/annals.1333.061 ISSN 0077-8923 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
JD Furber: Extracellular glycation crosslinks: prospects for removal. Rejuvenation Research, 2006, 9. vsk, nro 2, s. 274–278. PubMed:16706655 doi:10.1089/rej.2006.9.274 ISSN 1549-1684 Artikkelin verkkoversio.